The crucial roles of miR‐23a‐3p and its regulation of the TNFR1–NF‐κB pathway indicate promising avenues for future investigations, to optimize the treatment strategies for IBD and associated diseases and improve the patient outcomes. Here, NFKB1 is linked to inflammatory bowel disease.